Thomas David Hull III Sells 1,854 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

Kewaunee Scientific Corporation (NASDAQ:KEQUGet Free Report) CEO Thomas David Hull III sold 1,854 shares of the business’s stock in a transaction on Monday, September 29th. The shares were sold at an average price of $43.42, for a total transaction of $80,500.68. Following the completion of the transaction, the chief executive officer owned 39,719 shares of the company’s stock, valued at approximately $1,724,598.98. This represents a 4.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

  • On Wednesday, October 1st, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.09, for a total transaction of $43,090.00.
  • On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total transaction of $43,620.00.
  • On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The stock was sold at an average price of $44.00, for a total transaction of $31,724.00.
  • On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.34, for a total value of $35,047.82.
  • On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Stock Performance

NASDAQ KEQU opened at $43.31 on Friday. The stock has a market capitalization of $124.13 million, a price-to-earnings ratio of 10.49 and a beta of 0.68. The stock has a 50-day moving average of $51.96 and a 200 day moving average of $45.29. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last issued its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. The company had revenue of $71.10 million for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Saturday, July 5th.

Check Out Our Latest Research Report on KEQU

Institutional Trading of Kewaunee Scientific

A number of institutional investors have recently made changes to their positions in KEQU. Minerva Advisors LLC increased its position in shares of Kewaunee Scientific by 5.0% during the second quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company’s stock worth $4,501,000 after purchasing an additional 3,677 shares in the last quarter. American Century Companies Inc. boosted its stake in Kewaunee Scientific by 12.5% during the 2nd quarter. American Century Companies Inc. now owns 55,310 shares of the technology company’s stock worth $3,247,000 after purchasing an additional 6,128 shares during the last quarter. De Lisle Partners LLP grew its holdings in shares of Kewaunee Scientific by 6.7% during the second quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company’s stock worth $2,811,000 after buying an additional 3,029 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Kewaunee Scientific by 0.9% in the second quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock valued at $1,410,000 after buying an additional 223 shares during the last quarter. Finally, Punch & Associates Investment Management Inc. acquired a new stake in shares of Kewaunee Scientific in the first quarter valued at about $788,000. 32.69% of the stock is owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Recommended Stories

Insider Buying and Selling by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.